imatinib mesylate has been researched along with Myocardial Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breccia, M; Colafigli, G; Fegatelli, DA; FoĆ , R; Latagliata, R; Massaro, F; Molica, M; Scalzulli, E | 1 |
1 other study(ies) available for imatinib mesylate and Myocardial Ischemia
Article | Year |
---|---|
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biotransformation; Cardiovascular Diseases; Creatinine; Dasatinib; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Imatinib Mesylate; Kidney Tubules; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myocardial Ischemia; Protein Kinase Inhibitors; Pyrimidines; Renal Insufficiency, Chronic; Retrospective Studies; Young Adult | 2018 |